Impella Versus Intra-Aortic Balloon Pump in Patients With Cardiogenic Shock Treated With Venoarterial Extracorporeal Membrane Oxygenation: An Observational Study.
Ilhwan YeoRachel AxmanDaniel Y LuDmitriy N FeldmanJim W CheungRobert M MinutelloMaria G KarasErin M IannaconeAnkur SrivastavaNatalia I GirardiYoshifumi NakaShing Chiu WongLuke K KimPublished in: Journal of the American Heart Association (2024)
In patients with cardiogenic shock on VA-ECMO, LVU with Impella, particularly with 2.5/CP, was not associated with improved survival at 40 days but was associated with increased adverse events compared with IABP. More data are needed to assess Impella platform-specific comparative outcomes of LVU.
Keyphrases
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome
- respiratory failure
- aortic valve
- electronic health record
- left ventricular
- mechanical ventilation
- pulmonary artery
- type diabetes
- free survival
- adipose tissue
- metabolic syndrome
- skeletal muscle
- machine learning
- aortic dissection
- data analysis
- insulin resistance
- single cell
- pulmonary hypertension
- deep learning